New molecule could reverse neurodegeneration in Parkinson’s

News

Author: Simge Eva DoganPublished: 11 October 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

molecule

Researchers at a university in Spain have discovered a new molecule which they claim can block and reverse neurodegeneration in Parkinson’s.

The molecule – named SynuClean-D – is able to reduce alpha-synuclein aggregations which cause degeneration.

The study – published in science journal ‘PNAS’ – explains how researchers at the Universitat Autònoma de Barcelona, Spain, tested over 14,000 molecules before discovering SynuClean-D.

They then tested the molecule on a Caenorhabditis worm – one of the most commonly used animals when researching neurodegenerative diseases – finding that it boosted its mobility and protected it from neural degeneration.

Salvador Ventura, the study coordinator, said: “Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative diseases such as Parkinson’s in the future.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit Parkinson’s Europe website.

Go Back

Share this story

Comments


Related articles


sponsored article

Episodes

Podcast: Lessons learned from the pandemic

How has Parkinson’s disease community been impacted by Covid-19?

READ MORE
A picture of a cough medicine bottle with two packets of pills on a table

Advances

Could a cough medicine help slow the progression of Parkinson’s disease?

Researchers say this trial is “a big step forward”

READ MORE
Positive woman video calling using laptop. Businesswoman teleconferencing on laptop while working from home.

Global update

Parkinson’s in the news: January

This month’s Parkinson’s disease stories from around the globe

READ MORE